Work

1528P A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors

Year: 2023

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.1440

Authors: D. Olson, E.E. Dumbrava, M. George, S. Saibil, A. Giordano, M. Gavrilliuc, B. Pieke, E. Lichtenstein, M. Apostolopoulou, K. Moss, D. Kirkwood, S. Dang, D. Adib, B.L. Schlechter

Institutions: University of Chicago, The University of Texas MD Anderson Cancer Center, Rutgers Cancer Institute, University Health Network, Princess Margaret Cancer Centre, Dana-Farber Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387812409

FWCI:

Cites:

Cited by:

Related to: 10